| Ursodeoxycholic acid | Approved Investigational | SLC23A1 | 9963 |
upregulated | Ursodeoxycholic Acid results in increased expression of SLC23A1 mRNA | 5q31.2 | |
| Ursodeoxycholic acid | Approved Investigational | SLC23A2 | 9962 |
upregulated | Ursodeoxycholic Acid results in increased expression of SLC23A2 mRNA | 20p13 | |
| Ursodeoxycholic acid | Approved Investigational | SLC51A | 200931 |
upregulated | Ursodeoxycholic Acid results in increased expression of SLC51A mRNA | 3q29 | |
| Ursodeoxycholic acid | Approved Investigational | SLC51B | 123264 |
upregulated | Ursodeoxycholic Acid results in increased expression of SLC51B mRNA | 15q22.31 | |
| Ursodeoxycholic acid | Approved Investigational | TNFRSF10B | 8795 |
upregulated | Ursodeoxycholic Acid results in increased expression of TNFRSF10B mRNA | 8p21.3 | |
| Valproic acid | Approved Investigational | A2M-AS1 | 144571 |
downregulated | Valproic Acid results in decreased expression of A2M-AS1 mRNA | 12p13.31 | |
| Valproic acid | Approved Investigational | AAED1 | 195827 |
upregulated | Valproic Acid results in increased expression of AAED1 mRNA | 9q22.33 | |
| Valproic acid | Approved Investigational | AAGAB | 79719 |
upregulated | Valproic Acid results in increased expression of AAGAB mRNA | 15q23 | |
| Valproic acid | Approved Investigational | AAK1 | 22848 |
upregulated | Valproic Acid results in increased expression of AAK1 mRNA | 2p13.3 | |
| Valproic acid | Approved Investigational | AAMDC | 28971 |
upregulated | Valproic Acid results in increased expression of AAMDC mRNA | 11q14.1 | |
| Valproic acid | Approved Investigational | AASDH | 132949 |
downregulated | Valproic Acid results in decreased expression of AASDH mRNA | 4q12 | |
| Valproic acid | Approved Investigational | AASS | 10157 |
downregulated | Valproic Acid results in decreased expression of AASS mRNA | 7q31.32 | |
| Valproic acid | Approved Investigational | ABAT | 18 |
upregulated | Valproic Acid results in increased expression of ABAT mRNA | 16p13.2 | |
| Valproic acid | Approved Investigational | ABCA1 | 19 |
downregulated | Valproic Acid results in decreased expression of ABCA1 mRNA | 9q31.1 | |
| Valproic acid | Approved Investigational | ABCA1 | 19 |
upregulated | Valproic Acid results in increased expression of ABCA1 mRNA | 9q31.1 | |
| Valproic acid | Approved Investigational | ABCA13 | 154664 |
upregulated | Valproic Acid results in increased expression of ABCA13 mRNA | 7p12.3 | |
| Valproic acid | Approved Investigational | ABCA3 | 21 |
upregulated | Valproic Acid results in increased expression of ABCA3 mRNA | 16p13.3 | |
| Valproic acid | Approved Investigational | ABCA5 | 23461 |
downregulated | Valproic Acid results in decreased expression of ABCA5 mRNA | 17q24.3 | |
| Valproic acid | Approved Investigational | ABCB1 | 5243 |
upregulated | Valproic Acid results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Valproic acid | Approved Investigational | ABCB10 | 23456 |
upregulated | Valproic Acid results in increased expression of ABCB10 mRNA | 1q42.13 | |
| Valproic acid | Approved Investigational | ABCB4 | 5244 |
upregulated | Valproic Acid results in increased expression of ABCB4 mRNA | 7q21.12 | |
| Valproic acid | Approved Investigational | ABCB6 | 10058 |
upregulated | Valproic Acid results in increased expression of ABCB6 mRNA | 2q35 | |
| Valproic acid | Approved Investigational | ABCB7 | 22 |
downregulated | Valproic Acid results in decreased expression of ABCB7 mRNA | Xq13.3 | |
| Valproic acid | Approved Investigational | ABCC10 | 89845 |
upregulated | Valproic Acid results in increased expression of ABCC10 mRNA | 6p21.1 | |
| Valproic acid | Approved Investigational | ABCC2 | 1244 |
upregulated | Valproic Acid results in increased expression of ABCC2 mRNA | 10q24.2 | |